Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
GUT
Volume 66, Issue 1, Pages 180-190
Publisher
BMJ
Online
2016-09-20
DOI
10.1136/gutjnl-2016-312431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
- (2016) Fasiha Kanwal et al. Clinical Gastroenterology and Hepatology
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- NDI-010976, a Potent, Liver-Directed, Oral Inhibitor of Acetyl Coa Carboxylase for Non-Alcoholic Steatohepatitis: Pharmacodynamic Effects on Hepatic De Novo Lipogenesis in Obese but Otherwise Healthy Adult Male Volunteers
- (2016) W.F. Westlin et al. JOURNAL OF HEPATOLOGY
- Sitagliptin Versus Placebo in the Treatment of Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
- (2016) J.Y. Cui et al. JOURNAL OF HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- Reduction of Liver Steatosis and Fibrosis with an Ask1 Inhibitor in a Murine Model of Nash is Accompanied by Improvements in Cholesterol, Bile Acid and Lipid Metabolism
- (2016) G. Budas et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
- (2015) Hiroyuki Kato et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
- (2015) Daniele Pastori et al. DIGESTIVE AND LIVER DISEASE
- Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia
- (2015) Pierre Blais et al. DIGESTIVE DISEASES AND SCIENCES
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
- (2015) Rohit Loomba et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- P0932 : Treatment with NGM282 significantly improves liver histopathology in a mouse model of non-alcoholic steatohepatitis (NASH)
- (2015) J. Luo et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases
- (2015) M. Shiffman et al. JOURNAL OF HEPATOLOGY
- LP22 : Phase 1 results from PXS-4728A, a selective SSAO/VAP-1 inhibitor, for the treatment of non-alcoholic steatohepatitis
- (2015) W. Jarolimek et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis
- (2015) Mark R. Thursz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle Modifications
- (2015) Vi Nguyen et al. SEMINARS IN LIVER DISEASE
- miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease
- (2015) Qian Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
- (2014) Christian Gege et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects
- (2014) Rémy Hanf et al. Diabetes & Vascular Disease Research
- 850f Anti-NASH Effects of Solithromycin in NASH-HCC Mouse Model
- (2014) Prabhavathi Fernandes et al. GASTROENTEROLOGY
- Roles for Chemokines in Liver Disease
- (2014) Fabio Marra et al. GASTROENTEROLOGY
- Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation
- (2014) Takara L. Stanley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis
- (2014) Chris J. Weston et al. JOURNAL OF CLINICAL INVESTIGATION
- The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
- (2014) Fernando J. Barreyro et al. LIVER INTERNATIONAL
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation
- (2013) Shunlin Ren et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Peroxisome Proliferator–Activated Receptor δ Agonist GW1516 Attenuates Diet-Induced Aortic Inflammation, Insulin Resistance, and Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
- (2013) Lazar A. Bojic et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
- (2013) Rajendrakumar H. Jani et al. Diabetes Technology & Therapeutics
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis
- (2013) Philippe Mathurin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
- (2013) Rachel H. McMahan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice
- (2013) Shannon M Reilly et al. NATURE MEDICINE
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
- (2013) Jerry R. Colca et al. PLoS One
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver cholesterol: is it playing possum in NASH?
- (2012) Geoffrey C. Farrell et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy
- (2012) H. Nishizawa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
- (2012) Thuy-Anh Le et al. HEPATOLOGY
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
- (2012) Claudia O. Zein et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione
- (2012) Zhouji Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Malonyl-CoA: the regulator of fatty acid synthesis and oxidation
- (2012) Daniel W. Foster JOURNAL OF CLINICAL INVESTIGATION
- Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
- (2012) Geoffrey Porez et al. JOURNAL OF LIPID RESEARCH
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Treatment of NASH with ursodeoxycholic acid: Cons
- (2012) Fabia Liechti et al. Clinics and Research in Hepatology and Gastroenterology
- Treatment of NASH with ursodeoxycholic acid: Pro
- (2012) Vlad Ratziu Clinics and Research in Hepatology and Gastroenterology
- The Role of Chemokines in Acute Liver Injury
- (2012) Yedidya Saiman et al. Frontiers in Physiology
- Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease
- (2011) R. Dohil et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes
- (2011) Lihong Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells
- (2011) T. Adar et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents
- (2011) J. Mu et al. DIABETES
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
- (2011) Vincent Wai-Sun Wong et al. GUT
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNAs 103 and 107 regulate insulin sensitivity
- (2011) Mirko Trajkovski et al. NATURE
- Fatty Acid Bile Acid Conjugate Inhibits Hepatic Stearoyl Coenzyme A Desaturase and Is Non-atherogenic
- (2010) Alicia Leikin-Frenkel et al. ARCHIVES OF MEDICAL RESEARCH
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
- (2010) Adeline Bertola et al. PLoS One
- The Protein Kinase IKKɛ Regulates Energy Balance in Obese Mice
- (2009) Shian-Huey Chiang et al. CELL
- Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis
- (2009) Wing-Kin Syn et al. Clinics in Liver Disease
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Bile salt sequestration induces hepaticde novolipogenesis through farnesoid X receptor- and liver X receptorα-controlled metabolic pathways in mice
- (2009) Hilde Herrema et al. HEPATOLOGY
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
- (2009) Xinle Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
- (2009) Rania Abu-Hamdah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist
- (2008) Edward E. Cable et al. HEPATOLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
- (2007) Elisa Fabbrini et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now